SDHB and neoplasm: To characterize the genomic landscape of SDHB-mutant PCPG, we performed multi-omic analysis of an international (A5 consortium) cohort representing 94 primary and/or metastatic PCPG tumours from 79 patients (Fig. 1A) (see Supplementary Data 1 and 2 for clinical details).